Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Saved in:
Bibliographic Details
Title: Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.
Authors: Eijkelenkamp H; Department of Radiation-Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Verweij ME; Department of Radiation-Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Grimbergen G; Department of Radiation-Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Tanaka M; Department of Radiation-Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kensen CM; Department of Radiation-Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Janssen T; Department of Radiation-Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Vijlbrief T; Department of Radiation-Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Grevenstein WMU; Department of Surgery, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Moons LMG; Department of Gastroenterology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Koopman M; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Lacle MM; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Braat MNGJA; Department of Radiology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Maas M; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Consten ECJ; Department of Surgery, Meander Medical Centre, Amersfoort, the Netherlands.; Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands., Pronk A; Department of Surgery, Diakonessenhuis Utrecht Zeist Doorn, Utrecht, the Netherlands., Smits AB; Department of Surgery, Sint Antonius Hospital, Nieuwegein, the Netherlands., Heikens JT; Department of Surgery, Hospital Rivierenland, Tiel, the Netherlands., Elias SG; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Verkooijen HM; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Meijer GJ; Department of Radiation-Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Couwenberg A; Department of Radiation-Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Intven MPW; Department of Radiation-Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
Source: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2026 May 25; Vol. 60, pp. 101191. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-6308
DOI:10.1016/j.ctro.2026.101191